1
|
Ederhy S, Benhamou-Tarallo I, Chauvet-Droit M, Nhan P, Cohen R, Pinna B, Cholet C, Fenioux C, Champiat S, Salem JE, Soulat-Dufour L, Cohen AA. Cardiotoxicity Related to Immune Checkpoint Inhibitors. Curr Treat Options Cardio Med 2021. [DOI: 10.1007/s11936-020-00878-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
2
|
Ederhy S, Fenioux C, Cholet C, Rouvier P, Redheuil A, Cohen A, Salem JE. Immune Checkpoint Inhibitor Myocarditis With Normal Cardiac Magnetic Resonance Imaging: Importance of Cardiac Biopsy and Early Diagnosis. Can J Cardiol 2020; 37:1654-1656. [PMID: 33373722 DOI: 10.1016/j.cjca.2020.12.022] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2020] [Revised: 12/18/2020] [Accepted: 12/19/2020] [Indexed: 12/26/2022] Open
Abstract
Immune checkpoint inhibitors (ICIs) have improved the management and the prognosis of patients with cancer but are associated with an increased risk of toxicities that can affect every organ. ICI-associated myocarditis has a low incidence (< 1%) but a high fatality rate (30%-50%). Herein we report a patient treated with ICI admitted for suspicion of myocarditis. Cardiac magnetic resonance imaging (cMRI) was normal. An endomyocardial biopsy (EMB) was in favour of ICI-related myocarditis with cardiac lymphohistiocytic infiltrate. This case highlights the role of a systematic evaluation with electrocardiography and troponin and the potential value of EMB in patients without a suggestive cMRI.
Collapse
Affiliation(s)
- Stephane Ederhy
- Department of Cardiology, Assistance Publique‒Hôpitaux de Paris, Saint-Antoine Hospital, Paris, France and Sorbonne Université, UNICO-GRECO Cardio-oncology Program.
| | - Charlotte Fenioux
- Sorbonne Université, INSERM, CIC-1901 Paris-Est, UNICO-GRECO Cardio-oncology Program, Assistance Publique‒Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Department of Pharmacology, Paris, France
| | - Clement Cholet
- Department of Radiology, Assistance Publique‒Hôpitaux de Paris, Saint-Antoine Hospital, Paris, France
| | - Philippe Rouvier
- Department of Pathology, Pitié-Salpêtrière Hospital, Paris, France Sorbonne Université, Paris, France
| | - Alban Redheuil
- Sorbonne Université, Cardiothoracic Imaging Unit Hôpital Pitié-Salpétriêre, LIB INSERM, CNRS, ICAN Imaging, Institute of Cardiometabolism and Nutrition, Paris, France
| | - Ariel Cohen
- Department of Cardiology, Assistance Publique‒Hôpitaux de Paris, Saint-Antoine Hospital, Paris, France and Sorbonne Université, UNICO-GRECO Cardio-oncology Program
| | - Joe-Elie Salem
- Sorbonne Université, INSERM, CIC-1901 Paris-Est, UNICO-GRECO Cardio-oncology Program, Assistance Publique‒Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Department of Pharmacology, Paris, France; Department of Medecine, Cardio-oncology Program, Vanderbilt University Medical Center, Nashville, Tennessee, USA
| |
Collapse
|
3
|
Donadille B, Tuffet S, Cholet C, Nedelcu M, Bourcigaux N, Iserin L, Monnier-Cholley L, Rousseau A, Christin-Maitre S. Prevalence and progression of aortic dilatation in adult patients with Turner syndrome: a cohort study. Eur J Endocrinol 2020; 183:463-470. [PMID: 32822316 DOI: 10.1530/eje-20-0284] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/28/2020] [Accepted: 07/22/2020] [Indexed: 11/08/2022]
Abstract
OBJECTIVE Turner syndrome (TS) is a rare disorder affecting 1/2500 female newborn. Aortic dilatation (AD) and aortic dissection represent a major concern in TS. The aims of our study were to describe the aortic root growth, potential aortic dilatation (AD) risk factors and cardiovascular outcomes in a cohort of patients with TS. METHODS Among 204 adult patients included, 197 were studied using a standardized 1.5 Tesla MRI protocol. AD was defined as an aortic diameter ≥20 mm/m2 at the Valsalva sinuses and/or at the ascending aorta, when indexed to body surface area. RESULTS At baseline, AD was present in 81/197 (41.1%) and 32/197 (16.2%) of patients, at the levels of Valsalva and ascending aorta, respectively. The aortic Valsalva diameter was larger in patients treated for thyroiditis (P < 0.001). Potential risk factors of AD were aging (P < 0.001) and the presence of bicuspid aortic valve (BAV) (P = 0.002). The hazard ratio (HR) of AD occurrence in the presence of BAV was 2.2 (95% CI: 1.33-3.71). After a median follow-up period of 5.1 years (n = 143), AD was present in 58/143 (40.6%) and 25/143 (17.5%) of patients at the levels of Valsalva and ascending aorta, respectively. The median aortic growth of the Valsalva sinuses remained stable. At the ascending aorta, it increased by 0.14 ± 0.61 mm/year. Only one aortic-related death was observed. CONCLUSION AD is common in adult patients with TS. However, our results are rather reassuring, as the median aortic diameters remained stable after 5.1 years and few aortic events were observed.
Collapse
Affiliation(s)
- Bruno Donadille
- Endocrinology Department, Saint Antoine Hospital and Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Paris, France
- Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement (CRMERCD), Filière FIRENDO, Endo-ERN id 739527, Paris, France
| | - Sophie Tuffet
- Clinical Research Unit (URC-EST), Saint Antoine Hospital and Functional Unit of Pharmacology, Sorbonne Université, Paris, France
| | - Clement Cholet
- Radiology Department, Saint Antoine Hospital, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Paris, France
| | - Mariana Nedelcu
- Endocrinology Department, Saint Antoine Hospital and Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Paris, France
- Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement (CRMERCD), Filière FIRENDO, Endo-ERN id 739527, Paris, France
| | - Nathalie Bourcigaux
- Endocrinology Department, Saint Antoine Hospital and Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Paris, France
- Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement (CRMERCD), Filière FIRENDO, Endo-ERN id 739527, Paris, France
| | - Laurence Iserin
- Congenital Heart Disease Unit, Cardiology Department, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Laurence Monnier-Cholley
- Radiology Department, Saint Antoine Hospital, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Paris, France
| | - Alexandra Rousseau
- Clinical Research Unit (URC-EST), Saint Antoine Hospital and Functional Unit of Pharmacology, Sorbonne Université, Paris, France
| | - Sophie Christin-Maitre
- Endocrinology Department, Saint Antoine Hospital and Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Paris, France
- Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement (CRMERCD), Filière FIRENDO, Endo-ERN id 739527, Paris, France
- Inserm Unit UMR-S933, Paris, France
| |
Collapse
|
4
|
Cholet C, Dormont D, Law-Ye B. MR angiography of reversible cerebral vasoconstriction syndrome. Diagn Interv Imaging 2018; 99:525-526. [PMID: 30033143 DOI: 10.1016/j.diii.2018.07.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2018] [Revised: 06/30/2018] [Accepted: 07/02/2018] [Indexed: 11/28/2022]
Affiliation(s)
- C Cholet
- Department of Neuroradiology, CHU Pitié-Salpêtrière, AP-HP, 47-83, boulevard de l'Hôpital, 75013 Paris, France.
| | - D Dormont
- Department of Neuroradiology, CHU Pitié-Salpêtrière, AP-HP, 47-83, boulevard de l'Hôpital, 75013 Paris, France; Sorbonne Université, faculté de médecine Pierre-et-Marie-Curie, 91-105, boulevard de l'Hôpital, 75013 Paris, France
| | - B Law-Ye
- Department of Neuroradiology, CHU Pitié-Salpêtrière, AP-HP, 47-83, boulevard de l'Hôpital, 75013 Paris, France; Sorbonne Université, faculté de médecine Pierre-et-Marie-Curie, 91-105, boulevard de l'Hôpital, 75013 Paris, France
| |
Collapse
|
5
|
Benzakoun J, Cholet C, Pyatigorskaya N, Trunet S, Dormont D, Leclercq D, Law-ye B. Letter to the Editor: Can Vagus Nerve Schwannoma Masquerade as a Carotid Chemodectoma? J Maxillofac Oral Surg 2017; 16:400-401. [DOI: 10.1007/s12663-017-1012-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2017] [Accepted: 04/01/2017] [Indexed: 10/19/2022] Open
|
6
|
Affiliation(s)
- C Cholet
- Department of Diagnostic Radiology, Pitié-Salpêtrière Hospital, Paris, France.
| | - P-A Lampson
- Department of Diagnostic Radiology, Pitié-Salpêtrière Hospital, Paris, France; Pierre and Marie Curie University - Sorbonne Universités, Paris, France
| |
Collapse
|
7
|
Etienne G, Mathoulin-Pélissier S, Fort M, Guerci-Bresler A, Guilhot F, Rousselot PH, Nicolini FE, Legros L, Cholet C, Reiffers J, Mahon F. A phase II open trial evaluating imatinib mesylate and zoledronic acid in patients with chronic myeloid leukemia with molecular residual disease. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.18006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|